首页> 外文期刊>Cytometry, Part B. Clinical cytometry: the journal of the International Society for Analytical Cytology >The Use of Receiver Operating Characteristic Analysis for Detection of Minimal Residual Disease Using Five-Color Multiparameter Flow Cytometry in Acute Myeloid Leukemia Identifies Patients with High Risk of Relapse
【24h】

The Use of Receiver Operating Characteristic Analysis for Detection of Minimal Residual Disease Using Five-Color Multiparameter Flow Cytometry in Acute Myeloid Leukemia Identifies Patients with High Risk of Relapse

机译:使用五色多参数流式细胞术在急性髓样白血病中使用接收器工作特性分析检测最小残留疾病可确定复发风险高的患者

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Multiparameter flow cytometry (MFC) has been shown to be a useful approach for detection of minimal residual disease (MRD). The aim of the study was to determine the optimal threshold that can separate patients into two groups in terms of leukemic residual cells and relapse status after induction and consolidation chemotherapy. Methods: Five-color MFC and receiver operating characteristics (ROC) analysis were used to determine the optimal threshold. This study analyzed 54 acute myeloid leukemia (AML) patients. Results: LAPs were detected in 51/54 (94%) patients. MRD was evaluated in the bone marrow (BM) in morphologic complete remission from 25 and 22 patients after induction and consolidation, respectively. The threshold discriminating MRD- from MRD+ cases was set at 0.15% residual leukemic cells, a level that allowed optimal sensitivity and specificity for prediction of relapse, both at postinduction (P = 0.05) and postconsolidation (P = 0.009) time points using ROC analysis. MRD level postinduction not only influenced relapse-free survival (RFS) (P = 0.004) but also overall survival (OS) (P = 0.003). Multivariate analysis showed that MRD level postinduction was a powerful independent prognostic factor for both RFS (P = 0.037) and OS (P = 0.026). Conclusions: Using the ROC analysis, the threshold of 0.15% was defined as the optimal value in discriminating risk categories in AML, and postinduction MRD assessment is able to better predict disease outcome than consolidation. Therefore, MRD analysis by MFC could be used for refining the selection of therapeutic strategies and improving clinical outcome in individual patients. (C) 2008 Clinical Cytornetry Society
机译:背景:多参数流式细胞仪(MFC)已被证明是检测最小残留疾病(MRD)的有用方法。该研究的目的是确定最佳阈值,该阈值可以按照诱导和巩固化疗后的白血病残留细胞和复发状态将患者分为两组。方法:使用五色MFC和接收器工作特性(ROC)分析来确定最佳阈值。这项研究分析了54例急性髓细胞性白血病(AML)患者。结果:在51/54(94%)患者中检测到LAP。分别在25名和22名患者的诱导和巩固后,评估了其在骨髓(BM)中形态完全缓解的MRD。区分MRD +和MRD +病例的阈值设置为0.15%残留白血病细胞,该水平允许在ROC分析的诱导后(P = 0.05)和巩固后(P = 0.009)时间点,以最佳的敏感性和特异性预测复发。诱导后MRD水平不仅影响无复发生存期(RFS)(P = 0.004),而且还影响总生存期(OS)(P = 0.003)。多变量分析表明,MRD水平诱导后是RFS(P = 0.037)和OS(P = 0.026)的有力独立预后因素。结论:使用ROC分析,将0.15%的阈值定义为辨别AML风险类别的最佳值,并且诱导后MRD评估比合并巩固能够更好地预测疾病结果。因此,MFC的MRD分析可用于完善治疗策略的选择并改善个别患者的临床结局。 (C)2008临床椎体学会

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号